We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

3D Printed Diagnostic Device Rapidly Detects Anemia

By LabMedica International staff writers
Posted on 07 Mar 2016
Print article
Image: The Projet 1200 3D printer was able to easily produce and refine the device from environmentally friendly materials to make low cost, point-of-care devices that quickly detect anemia from a drop of blood (Photo courtesy of Kansas State University).
Image: The Projet 1200 3D printer was able to easily produce and refine the device from environmentally friendly materials to make low cost, point-of-care devices that quickly detect anemia from a drop of blood (Photo courtesy of Kansas State University).
A new biomedical device has been developed using 3D printers to create a low cost, point-of-care device that can quickly detect anemia, a condition in which the blood does not have enough healthy red blood cells to transport oxygen to the body's organs.

Point-of-care devices give the user fast, easy-to-understand results from a test performed outside of a laboratory, such as a blood glucose test or pregnancy test and identifying a blood disorder may be as easy as running a blood sample from a finger prick under a smartphone.

Scientists at Kansas State University (Olathe, KS, USA) made the device with a Projet 1200 3D printer (3DSystems; Rock Hill, SC, USA) and designed it to detect anemia for individuals who have limited access to health care, such as those living in developing countries. Anemia affects two billion people worldwide, including more than half of preschool children and pregnant women in developing countries and at least 30% of children and women in some industrialized nations.

The device consists of 3D printed clear plastic slides containing microfluidics that attach to a smartphone. The user adds a drop of their blood to a slide, which is used for a color scale-based test. The test results are produced in less than 60 seconds and can be read using a smartphone. A companion app is being developed with Steve Warren, PhD, an associate professor in electrical and computer engineering at Kansas State University, which could manage data from the blood sample and even send the results to a doctor.

Kim Plevniak, a master's student in biological and agricultural engineering, who worked on the device, said, “Anemia is a very prevalent condition in developing countries even though it is easily treated with iron supplements or vitamins and can be prevented with a healthy diet. Often in these developing countries people will have much easier access to smartphones than they will to doctors and trained medical professionals.”

Related Links:

Kansas State University 
3Dsystems


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: The QIAstat-Dx Respiratory Panel Plus has received U.S. FDA clearance (Photo courtesy of QIAGEN)

New Respiratory Syndromic Testing Panel Provides Fast and Accurate Results

Respiratory tract infections are a major reason for emergency department visits and hospitalizations. According to the CDC, the U.S. sees up to 41 million influenza cases annually, resulting in several... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more